Lehrstuhl für Innere Medizin I (Medizin 1)

Clinical experiences and predictors of success of treatment with vedolizumab in IBD patients: a cohort study (2021) Mühl L, Becker E, Müller T, Atreya R, Atreya I, Neurath M, Zundler S Journal article CRISPR/Cas9 in Gastrointestinal Malignancies (2021) Jefremow A, Neurath M, Waldner M Journal article, Review article Reframing immune-mediated inflammatory diseases (2021) Boutrid N, Rahmoune H, Schett G, McInnes I, Neurath M Journal article α4β7 integrin-dependent adhesion of T cells to MAdCAM-1 is blocked by vedolizumab in patients with chronic refractory pouchitis (2021) Melde M, Müller T, Schneider IHF, Geppert CI, Mühl L, Besendorf L, Allner C, et al. Journal article Corrigendum to "Lung and thymic carcinoids: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up": [Annals of Oncology 32 (2021) 439-451 (2021) Baudin E, Caplin M, Garcia-Carbonero R, Fazio N, Ferolla P, Filosso PL, Frilling A, et al. Journal article, Erratum Endoscopy as a Diagnostic Tool for Personalized Therapy in IBD: Prediction of Response to Biological Therapy (2021) Atreya R Journal article, Editorial Drug Therapy in Gastroenterology: Molecular Basis of IBD (2021) Neurath M Journal article, Editorial Autophagy in cancer therapy—molecular mechanisms and current clinical advances (2021) Ganzleben I, Neurath M, Becker C Journal article, Review article A Possible Distinct Molecular Subtype (Quintuple-Wildtype) of Metastatic Colorectal Cancer in First-Line Anti-EGFR Therapy with Cetuximab Plus FOLFIRI - Palliative Precision Therapy and a Multidisciplinary Treatment Approach: Interim Analysis of the IVOPAK II Trial with Early Results (2021) Wein A, Stöhr R, Kersting S, Siebler J, Merkel S, Busse D, Wolff K, et al. Journal article Genetically Single Generation and characterization of an endogenously tagged SPG11-human iPSC line by CRISPR/Cas9 mediated knock-in (2021) Krumm L, Pozner T, Kaindl J, Regensburger M, Günther C, Turan S, Asadollahi R, et al. Journal article